- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.01. | Eikon prices its IPO, seeking to raise $318m | ||
| 28.01. | Lilly allies with gene-editing firm Seamless on hearing loss | ||
| 28.01. | Boehringer drug scores in rare kidney disease FSGS | ||
| 28.01. | CMS's Medicare price negotiations start round three | ||
| 28.01. | UK biotech sees "strong finish" to 2025 financing | ||
| 28.01. | Introducing the Sunday Times Tech 100: Life sciences part 3 | ||
| 27.01. | China clears its first drug for chronic hepatitis D | ||
| 27.01. | Boehringer signs €1bn+ deal for Simcere IBD candidate | ||
| 27.01. | Roche claims midstage win for obesity injectable | ||
| 27.01. | Vaccination fall costs UK its measles elimination status | ||
| 27.01. | Introducing the Sunday Times Tech 100: Life sciences part 2 | ||
| 26.01. | Bausch Health hit as Xifaxan successor flunks trials | ||
| 26.01. | MSD said to have pulled back from Revolution Medicines deal | ||
| 26.01. | COPD patients will get access to Dupixent via NHS | ||
| 26.01. | Introducing the Sunday Times Tech 100: Life sciences part 1 | ||
| 23.01. | Digital osteoarthritis, bulimia tools backed for NHS use | ||
| 23.01. | Sanofi plans amlitelimab dermatitis filing after new readout | ||
| 23.01. | Corxel's raises $287m for obesity drug, and other financings | ||
| 23.01. | Change of heart as NICE backs prostate cancer drug Talzenna | ||
| 23.01. | Ovarian cancer data restores faith in Corcept's relacorilant | ||
| 22.01. | J&J says 2026 sales could top $100 billion | ||
| 22.01. | Amazon joins the AI health assistant movement | ||
| 22.01. | NICE backs Roche lupus drug that supports kidney function | ||
| 22.01. | US checks out of WHO, leaving its bill unsettled | ||
| 22.01. | 11 high-impact drugs to look out for in 2026 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.